In addition, we performed immunohistochemistry experiments on BC tissues at different stages and found that with the progression of BC, the expression levels of tumor stemness-related markers (CD44, OCT4, SOX2, NANOG) gradually increased (Supplementary Fig. 2A, B). The gene discussed is SOX2; the disease is breast cancer.